If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,275.00    -15.00 (-0.66%)
Bid:
2,275.00
Ask:
2,280.00
Spread: 5.00 (0.22%)
Market Cap: £3.07b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

16 May 2024 07:00

RNS Number : 6220O
RIT Capital Partners PLC
16 May 2024
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

 

16 May 2024

 

 

30 April 2024 Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 April 2024 (with debt at fair value) was 2,511p per £1 ordinary share (31 March 2024: 2,536p). This is after deduction of the first interim dividend of 19.5 pence per £1 ordinary share paid on 26 April 2024.

 

April 2024 Highlights

 

US and European equity markets declined in the month of April, with the S&P 500 returning -4.1% in the period and the STOXX Europe 600 returning -0.8%. Global indices also fell, with the MSCI ACWI (50% £) down -2.6% for the month. This was on the back of inflation data in the US coming in higher than anticipated, which caused a shift in market expectations regarding the timing and magnitude of interest rate cuts and led to the 2-year US Treasury yield rising above 5% for the first time since November 2023. Reduced expectations for interest rate cuts in the US saw the US dollar increase by +1% against sterling, while the price of gold reached an all-time high in the middle of April.

 

Our portfolio remained resilient during the month, with a total return of -0.2% in April. This was driven by gains from Private Investments offset by modest declines in our Quoted Equities book, while Uncorrelated Strategies held steady.

 

·

Our Quoted Equities book declined slightly, as healthy gains from certain US listed names and our holdings in China combined with our active portfolio hedging helped to shield the book from weakening in broader equity markets.

 

·

Private Investments were a solid contributor during the month, driven by gains from our private funds which reported updated valuations. As of 30 April, 87% of our private funds were held at 31 December reported valuations and 10% were held at 31 March reported valuations. All private direct holdings are valued at 31 December, in line with our half-yearly valuation process for these holdings.

 

·

Uncorrelated Strategies were resilient, with credit holdings finishing flat and gold positions gaining during the month.

 

·

Currencies also contributed positively during the month, driven by positive translation impacts from the US dollar's increase versus sterling.

 

·

For 2024, RIT has declared a dividend of 39 pence per share, an increase of 2.6% versus 2023 and representing the 10th consecutive year of dividend increases. The first instalment of 19.5 pence was paid on 26 April to shareholders of record on 5 April, and the second instalment will be paid in October 2024.

 

·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. Year to date as of 30 April, the Company has repurchased approximately 1.4 million shares on behalf of shareholders.

 

 

 

 

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDELFFZELLBBE
Date   Source Headline
17th Feb 20207:00 amRNSNet Asset Value(s)
5th Feb 20207:00 amRNSNet Asset Value(s)
7th Jan 20204:19 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSNet Asset Value(s)
15th May 20197:00 amRNSNet Asset Value(s)
12th Apr 20197:00 amRNSNet Asset Value(s)
3rd Apr 20193:59 pmRNSQUARTERLY DISCLOSURE - Listing Rule 15.6.8
22nd Mar 20194:01 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
18th Feb 20197:00 amRNSNet Asset Value(s)
5th Feb 20197:00 amRNSNet Asset Value(s)
8th Jan 201910:02 amRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Dec 20187:00 amRNSNet Asset Value(s)
30th Nov 201810:53 amRNSComposition of Board Committee
14th Nov 20187:00 amRNSNet Asset Value(s)
29th Oct 20184:59 pmRNSComposition of Board Committee
16th Oct 201811:11 amRNSDirector Declaration
12th Oct 20187:00 amRNSNet Asset Value(s)
5th Oct 20185:03 pmRNSDirector/PDMR Shareholding
4th Oct 20185:46 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Sep 20187:00 amRNSNet Asset Value(s)
24th Aug 20183:15 pmRNSAppointment of Joint Broker
14th Aug 20187:00 amRNSNet Asset Value(s)
7th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20186:00 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Jun 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
26th Apr 201812:41 pmRNSDirectorate Change
26th Apr 201812:27 pmRNSResult of AGM
16th Apr 20187:25 amRNSNet Asset Value(s)
6th Apr 20185:54 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
28th Mar 20185:09 pmRNSDirector/PDMR Shareholding
26th Mar 201811:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.